Header image

MORNING PLENARY SESSION - TUESDAY

Tuesday, November 14, 2023
8:42 AM - 10:55 AM
Hall L (plenary)

Overview

Keynote Address 4: SCOTT WILSON
Keynote Address 5: REBECCA McKETIN- Stimulant use harms and interventions: What we know and where to next


Speaker

Professor Kate Conigrave
Senior Staff Specialist And Conjoint Professor
Royal Prince Alfred Hospital

Tribute to/acknowledgement of the passing of James Rankin

8:40 AM - 8:50 AM

Biography

Agenda Item Image
Mr Scott Wilson
CEO
ADAC

James Rankin Oration

8:50 AM - 9:35 AM

Biography

Scott has been employed by the Aboriginal Drug and Alcohol Council (SA) Inc since November 1993. Scott's experience in the areas of substance use, misuse and abuse has seen him on nearly every major governmental and non-government committee in Australia over the past 30 years. In 2017, Scott was the recipient of the APSAD First Peoples Award Scott is Lead Convenor of SAACCON and Deputy Convenor of CoP
Agenda Item Image
Professor Leanne Hides
Deputy Director
National Centre For Youth Substance Use Research, The Univerity Of Queensland

APSAD Awards Ceremony 2

9:35 AM - 9:45 AM

Biography

Ms Felicity Wardle
Research Assistant
Menzies School of Health Research

Drug checking up north: would festival patrons in the NT use this harm reduction service?

9:47 AM - 9:48 AM

Abstract PDF

Digital Poster .pdf

Biography

Agenda Item Image
Ms Clare Rushton
PhD Candidate
University Of Wollongong

SMART Family and Friends: The feasibility of a video-conference-delivered intervention for Australian families affected by another’s methamphetamine use.

9:48 AM - 9:49 AM

Abstract PDF

Digital Poster .pdf

Biography

Clare is a Psychologist completing her PhD at the University of Wollongong, NSW. Her research is investigating the experiences of families affected by a loved one's alcohol or other drug use, and how to effectively address families' needs through the intersection of research and clinical practice.
Agenda Item Image
Ms Sally Underdown
State Manager SA & NT
Alcohol And Drug Foundation

Understanding how to create earlier pathways to AOD help and support: the right information, in the right format, at the right time

9:49 AM - 9:50 AM

Abstract PDF

Digital Poster .pdf

Biography

Eleanor is a health promotion and AOD prevention practitioner with over 20 years’ experience in public health, health promotion and prevention. She specialises in the development, delivery and evaluation of community-based programs, including leading the state-wide Drug Prevention Programs and the Public Education and Health Promotion area.
Ms Christina Norris
Research Officer
NCETA

"it’s very much about you as a role model, and your responsibilities as a parent": Parents’ perspectives on adolescent alcohol provision messaging

9:50 AM - 9:51 AM

Abstract PDF

Digital Poster .pdf

Biography

Christina Norris is a Research Assistant at NCETA with an interest in understanding the social context of health behaviours to support population-level behaviour change. She has been involved in a variety of AOD projects, including her primary focus of reducing parental supply of alcohol to adolescents through health promotion messaging.
Agenda Item Image
Prof Nadine Ezard
Director
National Centre for Clinical Research on Emerging Drugs

Oral Naltrexone-Bupropion Combination Pharmacotherapy for Methamphetamine Use Disorder: Pilot Study Protocol

9:51 AM - 9:52 AM

Abstract PDF

Digital Poster .pdf

Biography

Nadine is an Addiction Medicine clinician-researcher with 30 years’ experience in addiction medicine and public health practice in Australian and international contexts. A founding fellow of the Australian Chapter of Addiction Medicine, for the past decade she has held the position as Clinical Director of the Alcohol and Drug Service at St Vincent’s Hospital in Sydney, working as a practising Addiction Medicine specialist and leading a range of clinical services and innovations. Nadine is Professor with the National Drug and Alcohol Research Centre, University of New South Wales Faculty of Medicine, as the inaugural Director of the National Centre for Clinical Research on Emerging Drugs. She has previously worked for the World Health Organization, the United Nations High Commissioner for Refugees, and the United Nations Office of Drugs and Crime. Her current research focusses on working with people who use stimulants and related drugs to develop new and effective interventions, and she has a particular interest in substance use disorders among refugees and other displaced populations.
Associate Professor Caroline Salom
Principal Research Fellow
The University of Queensland

Driving under the influence: emerging findings from the Drug Trends study, 2021-2023

9:52 AM - 9:53 AM

Abstract PDF

Biography

Caroline is a substance use/mental health epidemiologist with additional interests in services to support people who use drugs and evaluation of these. She is the Queensland CI for Drug Trends and has worked in service provision as well as academia over the last 20 years.
Mr Joel Hillman
Clinical Research Pharmacist
University Of Sydney Faculty Of Medicine And Health

“Non Judgemental, Treated With Care and Respect”: First Reporting of Client Experience of Community Pharmacist Depot Buprenorphine Services

9:53 AM - 9:54 AM

Abstract PDF

Digital Poster .pdf

Biography

Joel (he/him) is a drug and alcohol pharmacist with practise experience in community, hospital, and academic pharmacy. He is passionate about substance-related care, accessibility of care, education, and opioids. He coordinates the NSW Depot Buprenorphine Pilot and teaches at the University of Sydney.
Dr Joshua Trigg
Lecturer/Researcher
Flinders University

Perspectives on limiting tobacco access and supporting access to nicotine vaping products among clients of residential drug and alcohol treatment services in Australia

9:54 AM - 9:55 AM

Abstract PDF

Biography

Dr Trigg is a behavioural scientist whose work focuses on health risk factors and attitudes, and motivators of risk-taking behaviour. He studies nicotine vaping, tobacco, and alcohol attitudes and behaviours, and preventive health communication design. He has also examined motivators and inhibitors of emergency behaviour, and quality of life.
Agenda Item Image
Ms Rebecca McKetin
Associate Professor
UNSW

Stimulant use harms and interventions: what we know and where to next

9:55 AM - 10:40 AM

Abstract PDF

Biography

Associate Professor Rebecca McKetin (BSc(Psychol)Hons. PhD) leads a program of research into stimulant use epidemiology and interventions at the National Drug and Alcohol Research Centre, UNSW. Rebecca’s current aspiration is to develop and disseminate effective treatment and harm reduction options for people using methamphetamine. Her work includes developing and evaluating online psychological self-help tools, pharmacotherapy trials and evaluating community-based treatment options. She is passionate about improving the coverage of treatment and other health services for people who use methamphetamine, and she has also done much research to help understand the relationship between methamphetamine use and mental health outcomes. Rebecca has consulted to the United Nations; she is a former NSW/ACT Young Tall Poppy, a Senior Editor for Addiction, a member of the UNSW Academic Board, and a member of the Australian Institute of Policy and Science.

Chairperson

Agenda Item Image
Leanne Hides
Deputy Director
National Centre For Youth Substance Use Research, The Univerity Of Queensland


Technical Host

Room One
Touchpoint

loading